Capital Fund Management (CFM)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
191,787
+146,481
| +323% | +$8.05M | 0.03% | 216 |
|
|
2025
Q1 | $3.2M | Sell |
45,306
-13,241
| -23% | -$936K | 0.01% | 455 |
|
|
2024
Q4 | $3.85M | Sell |
58,547
-92,349
| -61% | -$6.07M | 0.01% | 460 |
|
|
2024
Q3 | $10.6M | Buy |
150,896
+118,319
| +363% | +$8.32M | 0.03% | 211 |
|
|
2024
Q2 | $2.68M | Sell |
32,577
-7,522
| -19% | -$619K | 0.01% | 437 |
|
|
2024
Q1 | $3.5M | Buy |
+40,099
| New | +$3.5M | 0.01% | 380 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 602 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 620 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 571 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 580 |
|
|
2020
Q1 | – | Sell |
-8,872
| Closed | -$750K | – | 881 |
|
|
2019
Q4 | $750K | Buy |
+8,872
| New | +$750K | 0.01% | 566 |
|
|
2017
Q3 | – | Sell |
-4,635
| Closed | -$421K | – | 815 |
|
|
2017
Q2 | $421K | Sell |
4,635
-3,446
| -43% | -$313K | ﹤0.01% | 623 |
|
|
2017
Q1 | $709K | Buy |
+8,081
| New | +$709K | 0.01% | 619 |
|
|
2016
Q3 | – | Sell |
-98,181
| Closed | -$7.64M | – | 865 |
|
|
2016
Q2 | $7.64M | Buy |
+98,181
| New | +$7.64M | 0.07% | 172 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 858 |
|
|
2015
Q4 | – | Sell |
-137,052
| Closed | -$14.4M | – | 762 |
|
|
2015
Q3 | $14.4M | Buy |
137,052
+131,298
| +2,282% | +$13.8M | 0.16% | 89 |
|
|
2015
Q2 | $787K | Buy |
+5,754
| New | +$787K | 0.01% | 409 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 683 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 716 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 649 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 773 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 690 |
|
|
2013
Q3 | – | Sell |
-24,264
| Closed | -$1.35M | – | 700 |
|
|
2013
Q2 | $1.35M | Buy |
+24,264
| New | +$1.35M | 0.02% | 522 |
|